A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Clinical trial NCT06778863 · RECRUITING

Trial details

NCT number: NCT06778863
Sponsor: Clasp Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Unresectable Solid Tumor Metastatic Solid Tumor Colorectal Adenocarcinoma Pancreatic Adenocarcinoma Lung Cancer Ovarian Cancer Breast Cancer Head and Neck Squamous Cell Carcinoma Prostate Cancer Bladder Cancer

Start date: 2025-02-28
Primary completion: 2027-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.